Essa Pharma Stock Price History
EPIX Stock | USD 1.75 0.04 2.23% |
Below is the normalized historical share price chart for ESSA Pharma extending back to March 13, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ESSA Pharma stands at 1.75, as last reported on the 2nd of December, with the highest price reaching 1.82 and the lowest price hitting 1.73 during the day.
If you're considering investing in ESSA Stock, it is important to understand the factors that can impact its price. ESSA Pharma secures Sharpe Ratio (or Efficiency) of -0.0821, which denotes the company had a -0.0821% return per unit of volatility over the last 3 months. ESSA Pharma exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm ESSA Pharma's Standard Deviation of 10.27, market risk adjusted performance of 15.32, and Mean Deviation of 4.64 to check the risk estimate we provide.
At this time, ESSA Pharma's Total Stockholder Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 59.2 M in 2024, whereas Capital Stock is likely to drop slightly above 198.2 M in 2024. . At this time, ESSA Pharma's Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 0.19 in 2024, whereas Price To Sales Ratio is likely to drop slightly above 272.8 K in 2024. ESSA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 9th of July 2015 | 200 Day MA 5.9386 | 50 Day MA 4.2492 | Beta 1.84 |
ESSA |
Sharpe Ratio = -0.0821
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | EPIX |
Estimated Market Risk
10.37 actual daily | 92 92% of assets are less volatile |
Expected Return
-0.85 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average ESSA Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ESSA Pharma by adding ESSA Pharma to a well-diversified portfolio.
Price Book 0.6166 | Book Value 2.904 | Enterprise Value -50.9 M | Enterprise Value Ebitda (8.09) | Shares Float 21 M |
ESSA Pharma Stock Price History Chart
There are several ways to analyze ESSA Stock price data. The simplest method is using a basic ESSA candlestick price chart, which shows ESSA Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 12, 2024 | 7.1 |
Lowest Price | November 1, 2024 | 1.4 |
ESSA Pharma December 2, 2024 Stock Price Synopsis
Various analyses of ESSA Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ESSA Stock. It can be used to describe the percentage change in the price of ESSA Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ESSA Stock.ESSA Pharma Price Daily Balance Of Power | (0.44) | |
ESSA Pharma Price Rate Of Daily Change | 0.98 | |
ESSA Pharma Accumulation Distribution | 25,163 | |
ESSA Pharma Price Action Indicator | (0.05) |
ESSA Pharma December 2, 2024 Stock Price Analysis
ESSA Stock Price History Data
The price series of ESSA Pharma for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 5.7 with a coefficient of variation of 42.72. Under current investment horizon, the daily prices are spread out with arithmetic mean of 4.72. The median price for the last 90 days is 5.77. The company completed 1:20 stock split on 25th of April 2018. ESSA Pharma completed dividends distribution on 2018-04-25.Open | High | Low | Close | Volume | ||
12/02/2024 | 1.78 | 1.82 | 1.73 | 1.75 | 508,858 | |
11/29/2024 | 1.81 | 1.82 | 1.79 | 1.79 | 50,268 | |
11/27/2024 | 1.79 | 1.85 | 1.78 | 1.79 | 203,012 | |
11/26/2024 | 1.78 | 1.82 | 1.78 | 1.81 | 255,833 | |
11/25/2024 | 1.83 | 1.87 | 1.80 | 1.80 | 208,145 | |
11/22/2024 | 1.74 | 1.86 | 1.73 | 1.83 | 360,728 | |
11/21/2024 | 1.74 | 1.82 | 1.74 | 1.76 | 273,142 | |
11/20/2024 | 1.71 | 1.78 | 1.69 | 1.73 | 203,131 | |
11/19/2024 | 1.68 | 1.76 | 1.67 | 1.74 | 242,800 | |
11/18/2024 | 1.72 | 1.75 | 1.66 | 1.71 | 385,615 | |
11/15/2024 | 1.75 | 1.83 | 1.69 | 1.72 | 781,828 | |
11/14/2024 | 1.80 | 1.86 | 1.75 | 1.76 | 451,198 | |
11/13/2024 | 1.86 | 1.88 | 1.77 | 1.77 | 431,203 | |
11/12/2024 | 1.79 | 1.89 | 1.79 | 1.86 | 535,725 | |
11/11/2024 | 1.88 | 1.88 | 1.75 | 1.79 | 606,697 | |
11/08/2024 | 1.83 | 1.88 | 1.76 | 1.80 | 868,790 | |
11/07/2024 | 1.73 | 1.89 | 1.70 | 1.77 | 1,416,934 | |
11/06/2024 | 1.69 | 1.77 | 1.66 | 1.71 | 988,410 | |
11/05/2024 | 1.60 | 1.79 | 1.60 | 1.70 | 1,713,130 | |
11/04/2024 | 1.56 | 1.69 | 1.54 | 1.63 | 6,001,454 | |
11/01/2024 | 1.53 | 1.60 | 1.40 | 1.40 | 34,299,140 | |
10/31/2024 | 5.37 | 5.38 | 5.01 | 5.20 | 27,568 | |
10/30/2024 | 5.39 | 5.57 | 5.10 | 5.28 | 21,075 | |
10/29/2024 | 5.54 | 5.75 | 5.41 | 5.41 | 22,475 | |
10/28/2024 | 5.54 | 5.76 | 5.47 | 5.49 | 14,686 | |
10/25/2024 | 5.96 | 5.96 | 5.50 | 5.55 | 22,671 | |
10/24/2024 | 5.41 | 5.97 | 5.35 | 5.97 | 93,641 | |
10/23/2024 | 5.65 | 5.75 | 5.00 | 5.37 | 89,307 | |
10/22/2024 | 5.96 | 5.99 | 5.60 | 5.74 | 44,686 | |
10/21/2024 | 6.11 | 6.11 | 5.85 | 6.02 | 13,424 | |
10/18/2024 | 5.93 | 6.45 | 5.85 | 6.08 | 31,951 | |
10/17/2024 | 6.15 | 6.24 | 5.76 | 5.77 | 36,967 | |
10/16/2024 | 6.02 | 6.24 | 5.96 | 6.12 | 17,203 | |
10/15/2024 | 6.05 | 6.24 | 5.92 | 5.95 | 19,742 | |
10/14/2024 | 6.29 | 6.41 | 5.90 | 6.02 | 53,676 | |
10/11/2024 | 5.64 | 6.37 | 5.60 | 6.23 | 76,747 | |
10/10/2024 | 5.76 | 5.97 | 5.60 | 5.70 | 21,461 | |
10/09/2024 | 5.82 | 6.08 | 5.68 | 5.94 | 50,756 | |
10/08/2024 | 6.21 | 6.45 | 5.78 | 5.79 | 28,471 | |
10/07/2024 | 6.06 | 6.48 | 5.85 | 6.15 | 28,838 | |
10/04/2024 | 6.05 | 6.34 | 5.85 | 6.04 | 42,416 | |
10/03/2024 | 6.06 | 6.08 | 5.91 | 6.05 | 13,216 | |
10/02/2024 | 5.81 | 6.06 | 5.68 | 6.06 | 62,233 | |
10/01/2024 | 6.14 | 6.22 | 5.80 | 5.81 | 20,881 | |
09/30/2024 | 6.25 | 6.77 | 5.97 | 6.06 | 48,773 | |
09/27/2024 | 6.37 | 6.44 | 6.26 | 6.44 | 3,051 | |
09/26/2024 | 6.10 | 6.44 | 6.10 | 6.21 | 26,521 | |
09/25/2024 | 6.16 | 6.21 | 5.90 | 6.09 | 43,260 | |
09/24/2024 | 6.38 | 6.49 | 5.85 | 6.16 | 52,292 | |
09/23/2024 | 6.41 | 6.63 | 6.07 | 6.43 | 61,495 | |
09/20/2024 | 6.39 | 6.90 | 6.27 | 6.46 | 95,991 | |
09/19/2024 | 6.36 | 6.76 | 6.11 | 6.48 | 118,311 | |
09/18/2024 | 6.80 | 6.85 | 5.70 | 6.05 | 183,269 | |
09/17/2024 | 6.89 | 7.41 | 5.88 | 6.77 | 80,101 | |
09/16/2024 | 7.50 | 7.88 | 6.90 | 7.00 | 183,860 | |
09/13/2024 | 7.05 | 7.18 | 6.80 | 6.85 | 27,437 | |
09/12/2024 | 6.90 | 7.10 | 6.73 | 7.10 | 45,353 | |
09/11/2024 | 6.50 | 7.06 | 5.92 | 7.06 | 83,785 | |
09/10/2024 | 5.77 | 6.54 | 5.76 | 6.48 | 71,408 | |
09/09/2024 | 5.47 | 6.26 | 5.47 | 5.81 | 71,187 | |
09/06/2024 | 5.64 | 5.72 | 5.27 | 5.38 | 21,438 |
About ESSA Pharma Stock history
ESSA Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ESSA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ESSA Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ESSA Pharma stock prices may prove useful in developing a viable investing in ESSA Pharma
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 50.7 M | 53.2 M | |
Net Loss | -31.6 M | -30 M |
ESSA Pharma Quarterly Net Working Capital |
|
ESSA Pharma Stock Technical Analysis
ESSA Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
All Next | Launch Module |
ESSA Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ESSA Pharma's price direction in advance. Along with the technical and fundamental analysis of ESSA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ESSA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.04) | |||
Jensen Alpha | (0.64) | |||
Total Risk Alpha | (2.36) | |||
Treynor Ratio | 15.31 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for ESSA Stock Analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.